Delivery Order 75N91019D00024-75N91021F00006
Award Date
5/19/21
Potential Completion Date
4/17/26
Potential Value
$19M
Federal Agency
National Cancer Institute
Awardee
Leidos Biomedical Research Inc.
Ultimate Awardee
Leidos Holdings, Inc.
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,962,135.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, titled "FY20 CONSOLIDATED FACILITIES TASK ORDER D", supports facilities operations, maintenance, and other services at the National Institutes of Health (NIH) campus in Fort Detrick, Maryland. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC)...
This is a Delivery Order under a larger Indefinite Delivery Contract awarded by the National Cancer Institute (NCI), a civilian agency, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has a ceiling value of $7,367,698.00 and is for "COORDINATED FACILITIES REQUIREMENTS FOR FY22 TASK ORDER - B", with an ultimate completion date of October 24, 2025. This award is not associated with any set-aside designations. Leidos Biomedical Research Inc. is a...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $11,607,388.00 contract is for facilities services, with a period of performance ending on February 12, 2027. It is not a set-aside contract. Leidos Biomedical Research Inc. is an established contractor that serves as a Federally Funded Research and Development Center (FFRDC) for the NCI, providing a...
This is a Cost Plus Fixed Fee Delivery Order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The contract has a ceiling value of $27,653,756.00 and a period of performance through September 30, 2025. The purpose of this contract is to provide a wide range of biomedical research and facilities support services to the NCI, including operations and maintenance, research and development, clinical...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the NCI Federally Funded Research and Development Center (FFRDC) and has a ceiling value of $6,371,084.00. The contract period of performance runs through November 13, 2025. Leidos Biomedical Research Inc. provides a range of biomedical research and facilities support services to federal agencies, with a...
This is a task order awarded under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract worth up to $6.6 billion over 5 years, held by Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The task order is for $16,535,472.00 and is for facilities expansion work at the National Cancer Institute (NCI) campus in Frederick, Maryland. The contract is a Cost-Plus-Fixed-Fee type and has an ultimate completion date of June 18, 2026. Leidos Biomedical Research Inc. is the...
This is a cost-plus-fixed-fee delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for FY24/FY25 leases and operational support for the NCI's Federally Funded Research and Development Center (FFRDC). The award has a ceiling value of $26,538,136.00 and a period of performance through August 30, 2025. The work will be primarily performed at Leidos Biomedical Research facilities in...
This is a federal contract award to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to provide a Federally Funded Research and Development Center (FFRDC) contract to the National Cancer Institute (NCI) valued at $21,912,726.00. The contract is a cost-plus-fixed-fee delivery order with an ultimate completion date of August 29, 2025. The contractor will provide a comprehensive range of biomedical research and facilities support services to the NCI, including operations...
This federal contract award, with ID 75N91019D00024|75N91023F00013, was made by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for FY23 FACILITIES TO F services, with a ceiling value of $1,830,315.00. It is a Delivery Order contract with a Cost Plus Fixed Fee pricing type. The ultimate completion date is October 7, 2025, and the award date is September 27, 2023. This contract does not have a set-aside designation....
This is a $2,528,739 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is part of the NCI's Cancer Data Ecosystem program and has an ultimate completion date of April 30, 2026. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a wide range of...